Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With CisplatinJosé Baselga, John Mendelsohn, Gabriella D’Andrea et al.|Journal of Clinical Oncology|2000Cited by 746